4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-16-012634
CEO and Interim CFO bought 10,000 shares at an average $2.02 ($20,180)
From the SEC's structured data for this filing
Trades in this filing
DAVE KAUSHIK J · CEO and Interim CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-14 | Purchase : show line 1 in the form | +8,000 | $2.02 | $16,160 | 86,500 | D |
| 2016-04-14 | Purchase : show line 2 in the form | +2,000 | $2.01 | $4,020 | 88,500 | D |
| Open-market purchases · 10,000 sh · avg $2.02 · $20,180 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-15 | Grant or award : show line 3 in the form Options to purchase common stock | +400,000 | $1.99 | $796,000 | 400,000 | D |
Loading xslF345X03/f4041416dave_actiniumpharm.xml…